Physician profile
Lee Duke
NPI 1922051721
$425.71
in general payments reported to CMS, 2019-2025
10 companies · $275 in 2025
The $275 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.59 · 2020: $12.46 · 2021: $11.56 · 2022: $17.01 · 2023: $41.77 · 2024: $50.41 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $367.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $182.44 | 2020-2025 | Nucala |
| Astrazeneca Pharmaceuticals LP | $73.69 | 2021-2025 | Breztri, Airsupra, Fasenra |
| Insmed, INC. | $31.75 | 2025 | Arikayce |
| Takeda Pharmaceuticals U.S.A., INC. | $30.73 | 2024 | Glassia |
| Harmony Biosciences LLC | $25.02 | 2023 | Wakix |
| Grifols USA, LLC | $19.68 | 2024 | Prolastin-C Liquid |
| Jazz Pharmaceuticals INC. | $17.59 | 2019 | |
| Novartis Pharmaceuticals Corporation | $17.01 | 2022 | |
| Merck Sharp & Dohme LLC | $16.75 | 2023 | Belsomra |
| Breas Medical, INC. | $11.05 | 2025 | Vivo 45 Ls |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Duke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.